Scott Eric Schachter, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 300 James Way, Suite 210, Pismo Beach, CA 93449 Phone: 805-773-6000 Fax: 805-773-2120 |
Dr. Mona Kaur Gill, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 300 James Way Ste 210, Pismo Beach, CA 93449 Phone: 805-773-6000 Fax: 805-773-2120 |
Dr. Ken Peterson Family Optometry Optometrist Medicare: Medicare Enrolled Practice Location: 911 Oak Park Blvd, Suite 104, Pismo Beach, CA 93449 Phone: 805-473-9393 Fax: 805-473-1974 |
Advanced Eyecare-eyewear Optometry Optometrist Medicare: Medicare Enrolled Practice Location: 300 James Way Ste 210, Pismo Beach, CA 93449 Phone: 805-773-6000 Fax: 805-773-2120 |
Dr. Dennis Raoul Richardson, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 573 Five Cities Dr, Pismo Beach, CA 93449 Phone: 805-773-4700 Fax: 323-296-1062 |
Michael E. Jacobs, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 573 Five Cities Dr, Pismo Beach, CA 93449 Phone: 805-773-4700 Fax: 805-773-4248 |
Dr. Kenneth A Peterson, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 911 Oak Park Blvd Ste 104, Pismo Beach, CA 93449 Phone: 805-473-9393 Fax: 805-473-1974 |
Advanced Eyecare Central Coast Optometrist Medicare: Medicare Enrolled Practice Location: 300 James Way Ste 210, Pismo Beach, CA 93449 Phone: 805-773-6000 Fax: 805-773-2120 |
News Archive
Every day we are exposed to low levels of hundreds of different manmade chemicals present for example in our food, consumer products and the air we breathe.
The University of Maryland Schools of Dentistry (UM SOD) and Medicine (UM SOM) jointly announced today that they have received a five-year $10.7 million grant award from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health to study the causes, prevention and treatment of sexually-transmitted diseases (STDs).
A new study published on the preprint server bioRxiv* in August 2020 reports the preliminary results of the US Expanded Access Program (EAP) for CP. The EAP aimed to facilitate access to CP as well as to evaluate the safety of this therapy. However, the current study reports the results of an initial assessment of this agent.
Patients with myelodysplastic syndromes (MDS) suffer from a reduction in the number of different types of blood cells, including red blood cells leading to the development of anemia.
› Verified 3 days ago